Issue Information

2024-9-13

Dynamic Changes in ELF Score Predict Hepatocellular Carcinoma in Chronic Hepatitis B Patients Receiving Antiviral Treatment

2024-9-10

Socioeconomic Deprivation Weighs Heavily on Liver Fibrosis and Mortality After Hepatitis C Cure (ANRS CO22 Hepather)

2024-9-10

Cigarette Smoking Is Associated With Lower Chance of Hepatitis B Surface Antigen Seroclearance and Altered Host Immunity

2024-9-9

Individual Heterogeneity and Trends in Hepatitis C Infection Risk Among People Who Inject Drugs: A Longitudinal Analysis

2024-9-5

Evolving Characteristics of Decedents With Hepatitis A Listed as a Cause of Death, United States, 2011–2021

2024-9-3

Safety of Tenofovir Disoproxil Fumarate Among Breastfeeding Infants of Patients With Chronic Hepatitis B: A Systematic Review

2024-8-29

Issue Information

2024-8-20

Association of Hepatitis B Surface Antigen Levels With Long‐Term Complications in Chronic Hepatitis B Virus Infection: A Systematic Literature Review

2024-8-16

Epidemiology, Treatment Patterns and Survival in Canadian Patients With Chronic Hepatitis B‐Related Hepatocellular Carcinoma

2024-8-16

<scp>NLRP3</scp> Inflammasome Activation Mediates Hepatitis E Virus‐Induced Neuroinflammation

2024-8-13

Expanding Hepatitis C Virus Treatment in the New Mexico State Prison System: Using the ECHO Model for Provider and Prison Peer Education

2024-8-13

Mixed‐Genotype <scp>HCV</scp> Direct Acting Antiviral Outcomes: A <scp>CANUHC</scp> Analysis

2024-8-12

<scp>MiRNome</scp> Profiling of Circulating Extracellular Vesicles in Patients With Chronic Hepatitis D Undergoing Pegylated Interferon Alpha Treatment

2024-8-11

Epidemiology and Outcomes of Hepatitis E Virus‐Associated Hospitalisations in the United States With a Focus on Pregnancy: A Nationwide Population Study, 1998–2020

2024-8-11

Infectivity of Hepatitis B Virus Surface Antigen‐Positive Plasma With Undetectable <scp>HBV</scp>‐<scp>DNA</scp>: Can <scp>HBsAg</scp> Screening Be Discontinued in Egyptian Blood Donors?

2024-8-10

Post‐Diagnosis <scp>HCV RNA</scp> Testing Rates Prior to <scp>HCV</scp> Treatment Among People Living With <scp>HIV</scp> With <scp>HCV</scp> Antibody Positivity in the Asia‐Pacific Region

2024-8-8

Clinical Prevalence of Hepatitis D Virus Among Hepatitis B Patients in Sulaymaniyah Governorate, Northern Iraq

2024-8-7

Sustained Virological Response After Early Discontinuation of Hepatitis C Treatment

2024-8-7

Assessment of HBV variants and novel viral and immune biomarkers in chronic hepatitis B patients with metabolic dysfunction associated steatotic liver disease

2024-8-7

Outcomes of a 1‐Year Pilot Study Implementing Universal Hepatitis Delta Virus Testing Among Veterans With Chronic Hepatitis B

2024-8-5

Self‐reported hepatitis B testing among noninstitutionalized adults in the United States before the implementation of universal screening, 2013–2017: A nationwide population‐based study

2024-7-30

Severe acute hepatitis of unknown origin in children: Is it still a mystery? What role does adenovirus play?

2024-7-29

Hepatitis C epidemiology and treatment outcomes in Italy: Impact of the <scp>DAA</scp> era and the <scp>COVID</scp>‐19 pandemic

2024-7-27

Changes in the prevalence of hepatitis B and C viral infections in Sindh province, Pakistan: Findings from two sero‐surveys in 2007 and 2019

2024-7-26

The role of treatment of hepatitis C with direct‐acting antiviral agents on glycaemic control in diabetic patients: An updated systematic review and meta‐analysis

2024-7-24

Issue Information

2024-7-24

Modelling the potential impact of global hepatitis B vaccination on the burden of chronic hepatitis B in the United States

2024-7-22

Screening rates for hepatitis B and C among low‐income US veterans: Data from the National Veteran Homeless and Other Poverty Experiences Study

2024-7-10

Impact of <scp>COVID</scp>‐19 pandemic on hepatocellular carcinoma surveillance in British Columbia, Canada: An interrupted time series study

2024-6-24

Issue Information

2024-6-11

Elevated hepatitis B virus <scp>RNA</scp> levels in <scp>HBeAg</scp>‐positive patients with low‐level viraemia or previous low‐level viraemia

2024-6-10

Regarding the predictive role of <scp>CXCL16</scp> in liver inflammation in chronic hepatitis B patients

2024-6-10

The immune response in chronic <scp>HBV</scp> infection

2024-6-6

Investigating linkage to care following community‐based screening for hepatitis B virus in rural Senegal: A mixed methods study

2024-6-5

<scp>Network‐based</scp> strategies to combat <scp>HCV</scp>: Examining social and spatial drivers of transmission among <scp>PWID</scp> in New Delhi

2024-6-4

Towards hepatitis C virus elimination in Iran: A blueprint for comprehensive strategies

2024-6-3

Genetic substructure and host‐specific natural selection trend across vaccine‐candidate <scp>ORF</scp>‐2 capsid protein of <scp>hepatitis‐E</scp> virus

2024-5-28

Peer support for people living with hepatitis B virus—A foundation for treatment expansion

2024-5-26

Global elimination of <scp>HBV</scp>: Is it really achievable?

2024-5-26

Treatment decisions based on <scp>HBV DNA</scp>

2024-5-24

Factors affecting quality of life in hepatitis B patients in Herat, Afghanistan: A case–control study

2024-5-24

Epidemiology, linkage to care and natural history of women of childbearing age with chronic hepatitis B: A population‐based study

2024-5-21

A novel test and treat program for hepatitis C virus infection utilizing <scp>HCV</scp> core antigen testing, among police and general population, Islamabad, Pakistan, 2022

2024-5-21

Current research insights into the role of <scp>CTLA</scp>‐4 in hepatitis B virus (<scp>HBV</scp>) infection

2024-5-21